Business Context and Reporting Period
Company: AMBEV S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: First Quarter ended March 31, 2022 (1Q22)
Context: Ambev reported solid top-line performance driven by the return of out-of-home consumption in Brazil and consistent execution of premiumization strategies. The quarter faced challenges including a new wave of COVID-19 variants in January, the cancellation of Carnival festivities in Brazil, and significant commodity price inflation.
Key Financial Metrics
| Metric | 1Q22 (R$ million) | 1Q21 (R$ million) | Change (Organic) |
|---|---|---|---|
| Net Revenue | 18,439.2 | 16,639.8 | +18.5% |
| Normalized EBITDA | 5,522.9 | 5,327.2 | +10.2% |
| Normalized Profit | 3,551.6 | 2,761.9 | +28.6% |
| Cash Flow from Operating Activities | 519.8 | 2,836.9 | -81.7% |
| Net Debt/(Cash) | (11,155.8) | (15,411.3) | Net cash position reduced |
| Total Consolidated Debt | 2,986.3 | 3,100.5 | -3.7% |
Margins: Normalized EBITDA margin decreased 220 basis points to 30.0% (from 32.0% in 1Q21) due to cost pressures. Gross margin declined 330 basis points to 48.9%.
Material Changes vs. Prior Period
- Volume Growth: Organic volume increased 3.6% to 45.1 million hectoliters. Growth was led by Brazil Non-Alcoholic Beverages (NAB) (+16.9%), Latin America South (LAS) (+2.9%), and Brazil Beer (+2.1%).
- Revenue Drivers: Net revenue per hectoliter (NR/hl) grew 14.5% organically, driven by price increases and mix shifts. LAS saw the highest NR/hl growth at 36.8%.
- Cost Pressures: Cash COGS per hectoliter increased 23.4% due to commodity headwinds. SG&A expenses grew 14.8%, primarily due to diesel inflation, partially offset by lower variable compensation accruals.
- Regional Performance:
- Brazil: Strong recovery in out-of-home consumption post-Omicron wave.
- Canada: Volume declined 8.4% due to a weak industry and strong prior-year comparisons; Normalized EBITDA fell 23.2%.
- CAC: Volume declined 4.7% due to supply chain constraints (bottle shortages in Dominican Republic), though EBITDA grew 4.7%.
- Argentina Impact: Application of Hyperinflation Accounting (IAS 29) resulted in a positive R$ 331.1 million adjustment in finance results and a positive impact on profit.
Guidance, Outlook, and Risks
- Guidance: Management maintained its FY 2022 guidance for Cash COGS/hl growth between 16-19% (excluding non-Ambev marketplace products).
- Outlook: Management expects continued execution of commercial strategy focused on premiumization, innovation, and digital monetization. The company aims to lead category growth and optimize the business.
- Risks and Contingencies:
- Commodity Prices: Continued pressure on input costs remains a primary risk.
- Supply Chain: Constraints in specific markets (e.g., CAC) impacted volume.
- FX Volatility: Significant losses on derivative instruments (R$ 708 million) related to FX hedging in Argentina and Brazil.
- Regulatory/Accounting: Ongoing impacts of hyperinflation accounting in Argentina.
- Unusual Items: Exceptional items totaled R$ 27.2 million in 1Q22 (down from R$ 71.4 million in 1Q21), primarily related to restructuring and residual COVID-19 expenses.
Investor Verification Checklist
- Cash Flow Volatility: Verify the sustainability of operating cash flow given the 81.7% decline, attributed to timing of variable compensation and capex payments.
- Margin Compression: Assess the ability to pass on cost increases to consumers to stabilize gross and EBITDA margins in the face of 23.4% COGS growth.
- Argentina Accounting: Review the specific impact of IAS 29 hyperinflation adjustments on reported revenue and EBITDA to understand underlying operational performance.
- Canada Performance: Monitor the turnaround strategy in Canada, where volume and EBITDA declined significantly due to industry weakness and strong prior-year comps.
- FX Hedging Costs: Evaluate the R$ 708 million loss on derivative instruments and its impact on net finance results.